SKOJOY Trademark

Trademark Overview


On Friday, February 10, 2023, a trademark application was filed for SKOJOY with the United States Patent and Trademark Office. The USPTO has given the SKOJOY trademark a serial number of 97790196. The federal status of this trademark filing is PUBLISHED FOR OPPOSITION as of Tuesday, March 12, 2024. This trademark is owned by Amgen Inc.. The SKOJOY trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure
skojoy

General Information


Serial Number97790196
Word MarkSKOJOY
Filing DateFriday, February 10, 2023
Status686 - PUBLISHED FOR OPPOSITION
Status DateTuesday, March 12, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 12, 2024

Trademark Statements


Goods and ServicesPharmaceutical preparations and substances for use in the treatment of hematological, immune, autoimmune, inflammatory and respiratory diseases and disorders; pharmaceutical preparations and substances for the treatment of cancer and cardiovascular diseases and disorders; pharmaceutical preparations and substances used for the treatment of blood cells and blood vessel diseases and disorders; pharmaceutical preparations and substances for the treatment of oncological, and ophthalmic diseases and disorders; pharmaceutical preparations and substances for the treatment of inflammatory disorders of the central nervous system; pharmaceutical preparations and substances used for the treatment of hemolytic anemia, thrombocytopenia and kidney failure

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 1, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAmgen Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Party NameAmgen Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799

Trademark Events


Event DateEvent Description
Tuesday, March 12, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 12, 2024PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 21, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, February 2, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, January 10, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, January 9, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 9, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, September 29, 2023APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Friday, September 29, 2023APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Wednesday, August 16, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, August 16, 2023NON-FINAL ACTION E-MAILED
Wednesday, August 16, 2023NON-FINAL ACTION WRITTEN
Tuesday, August 15, 2023ASSIGNED TO EXAMINER
Wednesday, March 1, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, February 14, 2023NEW APPLICATION ENTERED